Request Your Free On-Demand Webinar Now:

"Current Trends in Nucleic Acid Testing for HIV and HCV"

In this webinar, four experts discuss current trends in molecular testing for HIV and HCV including the impact of expanded molecular testing capacity post-pandemic and the extent to which new assays and instrumentation are allowing laboratories to address industry-wide challenges like staffing shortages and the need for workflow flexibility.

Nucleic acid testing is an essential tool for the diagnosis and management of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections. Recent regulatory approvals have brought new molecular tools to market, allowing labs to streamline their testing workflows. At the same time, the expansion of molecular capacity during the COVID-19 pandemic has changed the nucleic acid testing landscape.

Offered Free by: Hologic
See All Resources from: Hologic